| Aktienanzahl | 43,54 Mio. |
| Aktientyp | Stammaktie |
Intellipharmaceutics Provides Update on FDA Advisory Committees Meeting for Rexista™ (oxycodone hydrochloride extended release), an Abuse-Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
http://www.intellipharmaceutics.com/releasedetail.cfm?ReleaseID=1034629